World Peptide Congress 2026: the science behind Renova
Our content doesn't come from nowhere. We follow the world's leading peptide educators and researchers โ the SSRP Institute and its World Peptide Congress. This is a research-framed summary of the core ideas from the 2026 edition, and how they connect to our technical guides.
Our founder is a member of the SSRP Institute (Seeds Scientific Research & Performance), the cellular-medicine education and research community behind the World Peptide Congress. Training with them keeps our educational content current with the science.
This membership reflects our educational commitment. It does not imply SSRP Institute endorsement of any product, nor clinical certification of the compounds. All of our content is for research purposes only.
The World Peptide Congress 2026 brought together 17 speakers โ physicians, researchers and clinicians โ around a single idea: peptides are not standalone drugs but signaling tools that work only as well as the biological system they're applied to. That frame, "cellular medicine," is what organizes our guides.
Cellular medicine: peptides are tools, not magic bullets
Dr. William Seeds, founder of the SSRP Institute, sums up the field in one line: "peptides are the tools; cellular medicine is the operating system." His reasoning chain โ Source โ Signal โ Reprogram โ Protect โ says you first find the upstream driver (redox, inflammation, insulin resistance, mitochondria), then apply the right signal, in the right order, and protect the system from over-signaling.
For the research user, the practical lesson is the same one our peptide stacking guide teaches: combine complementary pathways, change one variable at a time, and respect the sequence.
The mitochondria, center of repair
Several talks (Jamie Gabel, PA-C; Kelli Musa) converge on the mitochondria as the thing being repaired. Three mitochondrial peptides cover three distinct axes: SS-31 stabilizes the inner membrane and cardiolipin; MOTS-c activates AMPK and metabolic flexibility; Humanin provides anti-apoptotic cytoprotection.
Go deeper in our guides on SS-31 (elamipretide) and MOTS-c.
GLP-1: beyond weight
Three speakers (Rhonda Bonilla, MSN; Sal Di Stefano; Kelli Musa) reframe GLP-1 agonists as multisystem metabolic signaling tools โ weight loss is a side effect of better cellular efficiency. The clinical caveat repeated across the congress: preserve muscle mass with resistance training and adequate protein.
Our guides cover the biology: how GLP-1 agonists work, Tirzepatide vs Retatrutide, Retatrutide (triple agonist) and the complete fat-loss guide.
Hormones and peptides, better together
Dr. Lindsey Berkson puts it this way: "hormones create the physiologic environment in which peptides operate." Without a healthy hormonal and mitochondrial environment, peptides underperform. The growth-hormone (GH) axis declines in parallel with the sex hormones.
Context in our GH-axis guides: CJC-1295 + Ipamorelin and Tesamorelin.
Terrain, barrier and regeneration
Dr. Siobhan Newman reframes autoimmunity as the immune system responding to a broken cellular "terrain" โ read and restore four layers (metabolism, mitochondria, inflammation, barrier) before suppressing. Dr. Kyle Koski extends the idea to the mouth as the start of systemic signaling. And in regeneration, Dr. Lauren Fitzgerald presents GHK-Cu (copper-tripeptide) as a broad "repair signal" that falls ~60% with age.
Related guides: GHK-Cu, KPV, GLOW vs KLOW, Wolverine (BPC-157 + TB-500) and Thymosin ฮฑ1.
Longevity and senescent cells
At the longevity layer, the congress discusses clearing senescent ("zombie") cells, epigenetic clocks as a response measure, and NAD+ restoration โ with a caveat: "repleting NAD+ without addressing upstream inflammation is like fueling a broken engine."
See Epithalon and NAD+ and cellular longevity.
The 17 talks of the 2026 Congress
The full program, as an educational reference to the scope of the field:
- Lea Llovio, CWL โ Before the protocol: practitioner congruence, trust, and outcomes.
- Stephen Matta, DO โ Stacking biologics with peptides: from pain to performance.
- Sal Di Stefano โ Aesthetics from the inside-out: adherence beats intensity.
- Siobhan Newman, MD โ Reframing autoimmunity: a terrain-first approach.
- Omar Rahman, MD โ Tendinopathy through the cellular lens: pathology to peptide.
- William Seeds, MD โ The top 10 disease models shaping peptide therapy.
- Lindsey Berkson โ Signal & amplify: hormones and peptides together.
- Jamie Gabel, PA-C โ SS-31, MOTS-c and Humanin: mitochondrial efficiency.
- Lauren Fitzgerald, MD โ Copper, collagen and cellular renewal: GHK-Cu.
- Kelli Musa, FMP โ The mismanaged generation: a metabolic problem.
- Gerald Morris, MD โ Shockwave + peptides: synergy in orthotripsy.
- Sharon Hausman-Cohen, MD โ Precision medicine: genomics and peptides.
- Rhonda Bonilla, MSN โ Beyond pounds: the power of GLP-1 peptides.
- Amal Ismail, CPNI โ Beyond the centile: a cellular & psychoneuroimmune frame.
- Anthony Castore โ You can't out-hack your biology: work with the body.
- Tammy Wolf, RN โ What aesthetics isn't telling you: biology first.
- Kyle Koski, DMD โ We Belong Together: the mouth as the mirror to medicine.
Educational summary for research purposes. Many of the uses discussed at the congress are off-label or investigational. This is not medical advice or a clinical protocol.
โ For research purposes only. Not medical advice. SSRP Institute membership is educational and does not imply product endorsement.